Testosterone therapy could increase the risk of death, heart attack, and stroke in men with “significant medical comorbidities,” according to a recent report in the Journal of the American Medical Association (JAMA).
The U.S. Food and Drug Administration (FDA) is investigating the safety of certain testosterone products after two studies suggested increased risk of heart attack, stroke, and death.
Obese teenagers may have up to 50% less total testosterone than their normal-weight peers, according to researchers from the State University of New York at Buffalo’s School of Medicine and Biomedical Sciences.
Adding testosterone to sildenafil (Viagra) for treatment of erectile dysfunction may not significantly improve the condition, according to American and Swiss researchers.
Men who take long-acting opioids for chronic pain appear to be at greater risk of developing low testosterone than men taking short-acting opioids, American researchers have found.
Testosterone replacement therapy using long-acting testosterone undecanoate (TU) improved several sexual function domains in men with type 2 diabetes, British researchers have shown.